WHO WE ARE
I left a Cambridge professorship to build ZOMP. The industry doesn’t need more niche microscopes; it needs massive, high-throughput spatial data. By pairing 3D label-free imaging with AI, we analyze millions of live cells—clearing manufacturing bottlenecks to make life-saving therapies accessible.
Gillies founded two companies prior to co-founding ZOMP. With two decades of experience in commercial leadership and building high-performance teams, he leads the commercial vision.
Dorottya brings expertise in imaging and conventional flow cytometry, gained through advanced cellular analysis during her PhD and high-throughput testing in industry. Her knowledge of complex data and assay development helps unlock the full potential of our technology for clinical and research applications.
Lukas brings expertise in experimental optics and photonics to ZOMP’s product development team. With his experience in interdisciplinary research he is leading ZOMP’s Product Integration efforts. He is committed to developing innovative solutions using cutting-edge technology
Jans’ expertise is in optics, image reconstruction and analysis, which he applied to various microscopy-related problems during his PhD (Jena, Germany) and Postdoc (Oxford, UK). At ZOMP he is focused on extracting 3D spatial & spectral information on a large scale population basis, pushing the frontiers of data analysis towards the goal of true imaging flow cytometry.
SCIENTIFIC ADVISORY BOARD
Andrew is one of the leading exponents of cytometry and an emerging leader in the field. His expertise includes cell sorting, analytical cytometry and image-based cytometry.
Adrian has 25 years experience in drug development and specialises in Cell Biology, Assay Development, High Throughput Screening & the application of Machine Learning.
